5AM Venture Management’s Avidity Biosciences RNAM Stock Holding History

5AM Venture Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-665,555	Closed	-$17M	–	30
2024 Q1	$17M	Hold	665,555	–	–	3.8%	10
2023 Q4	$6.02M	Hold	665,555	–	–	1.6%	20
2023 Q3	$4.25M	Hold	665,555	–	–	1.22%	22
2023 Q2	$7.38M	Hold	665,555	–	–	1.84%	15
2023 Q1	$10.2M	Hold	665,555	–	–	2.61%	10
2022 Q4	$14.8M	Buy	665,555 +275,000	+70%	+$4.1M	3.97%	9
2022 Q3	$6.38M	Hold	390,555	–	–	1.22%	16
2022 Q2	$5.67M	Hold	390,555	–	–	1.4%	16
2022 Q1	$7.21M	Hold	390,555	–	–	1.58%	14
2021 Q4	$9.28M	Sell	390,555 -165,000	-30%	-$3.94M	1.74%	13
2021 Q3	$13.7M	Buy	+555,555	New	+$12.1M	2.78%	11

Other funds holding RNAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

5AM Venture Management's RNAM Position: Q2 2024 in Review

5AM Venture Management sold out of Avidity Biosciences (RNAM) in Q2 2024, closing a stake of 665,555 shares — an estimated $17M sold.

5AM Venture Management first reported a position in RNAM in Q3 2021 and held it in 11 quarters. The position peaked at $17M in Q1 2024. 196 funds tracked by Wall St. Rank hold RNAM as of Q2 2024.

5AM Venture Management reported no remaining Avidity Biosciences position as of Q2 2024 after selling out during the quarter.
5AM Venture Management sold 665,555 Avidity Biosciences shares in Q2 2024, an estimated $17M.
5AM Venture Management first reported a position in Avidity Biosciences in Q3 2021 and held it in 11 quarters.
5AM Venture Management's Avidity Biosciences position peaked at $17M in Q1 2024.
196 funds tracked by Wall St. Rank held Avidity Biosciences as of Q2 2024.

Based on 5AM Venture Management's 13F filing for Q2 2024, filed 14 Aug 2024.